Cell-specific inhibition of p38alpha as a therapeutic strategy for inflammatory bowel disease. [electronic resource]
- Gastroenterology Apr 2010
- 1237-9 p. digital
Publication Type: Comment; Editorial; Research Support, N.I.H., Extramural
1528-0012
10.1053/j.gastro.2010.02.030 doi
Animals Enzyme Inhibitors--therapeutic use Humans Inflammatory Bowel Diseases--drug therapy Intestinal Mucosa--enzymology Mice Mitogen-Activated Protein Kinase 14--antagonists & inhibitors Myeloid Cells--enzymology